TG

Tintah Grace

North America, California, United States

Description

Tintah Grace

Investor Profile

Tintah Grace has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Precision Medicine
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tintah Grace frequently co-invest with?

PS
North America, Arizona, United States, Phoenix
Co-Investments: 1
Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 1
GF
Europe, Ticino, Switzerland, Lugano
Co-Investments: 1
Deep Insight
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 1
Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Compound
North America, New York, United States, New York
Co-Investments: 1
OurCrowd
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 1
Bold Capital Partners
North America, California, United States, Santa Monica
Co-Investments: 1
FV
North America, Florida, United States, West Palm Beach
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by Tintah Grace?

Bionaut Labs

Los Angeles, California, United States

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

BiopharmaBiotechnologyHealth CarePrecision MedicineTherapeutics
Series BNov 28, 2022
Amount Raised: $43,200,000